Browse By

4 analysts given BUY rating to ImmunoGen, Inc. (NASDAQ:IMGN)

ImmunoGen, Inc. (NASDAQ:IMGN)’s stock on Thursday traded at beginning with a price of $5.49 and when day-trade ended the stock finally declined -1.64% to reach at $5.40. Analyst’s mean target price for IMGN is $7.67 while analysts mean recommendation is 2.10. Stock value has moved between $1.51 – 8.06 in last one year.

Stock has got OUTPERFORM rating from 1 analyst(s) whereas last month 0 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 4 analyst(s) given BUY rating to the stock. Company fiscal year is ending in December and analysts’ consensus recommendation is Outperform for IMGN and estimated EPS for next quarter is $ -0.30 .

ImmunoGen, Inc. (NASDAQ:IMGN) yearly performance is 82.43%. Annual EPS Growth of past 5 years is 1.00%. The current share price indicates that stock is -32.84% away from its one year high and is moving 257.62% ahead of its 52-week low.

On 03 August 2017, MicroVision, Inc. (NASDAQ:MVIS) stock price started the day at $2.39 and moved between $2.26 – 2.55 to finally close at $2.45. MVIS’s distance from 20 day simple moving average is 6.11% and distance from 50-Day simple moving average is 14.18%. In last 4 months performance of MVIS was 21.89% while its price to sale ratio is 14.93 and price to book ratio is 81.67.

Analysts expect MicroVision, Inc. (NASDAQ:MVIS) to report $ -0.09 EPS and has got OUTPERFORM rating from 1 of Thomson Reuters analysts and 0 analyst(s) given UNDERPERFORM rating. Analyst’s mean target price for MVIS is $3.67 while analysts mean recommendation is 1.70. Firm LT growth rate is estimated as 0.85 %.

Brocade Communications Systems, Inc. (NASDAQ:BRCD)‘s stock on Thursday traded at beginning with a price of $12.60 and when day-trade ended the stock finally declined -1.27% to reach at $12.43. Analyst’s mean target price for BRCD is $12.63 while analysts mean recommendation is 3.00. Stock value has moved between $8.63 – 12.68 in last one year.

Analyst’s ratings play a very important role in outlining a stock’s performance. Let us check out how analysts have ranked BRCD based on current scenarios. Stock has got OUTPERFORM rating from 0 analyst(s) whereas last month 0 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 0 analyst(s) given BUY rating to the stock. Company fiscal year is ending in October and analysts’ consensus recommendation is Hold for BRCD and estimated EPS for next quarter is $ 0.17 .

Brocade Communications Systems, Inc. (NASDAQ:BRCD) yearly performance is 34.67% and net profit margin is 2.50%. Annual EPS Growth of past 5 years is 38.20%. The current share price indicates that stock is -2.28% away from its one year high and is moving 43.87% ahead of its 52-week low.

Leave a Reply

Your email address will not be published. Required fields are marked *